Andrew Stone
Andrew Stone
Latest posts from :
MSLs will need to respond to the growing demands being placed on them in the...
Pharma can improve outcomes, products and HCP relationships using technology to...
AstraZeneca’s innovations in chronic kidney disease are pointing the way to...
The events of 2020 have compelled pharma to reimagine the role of the rep to...
The sudden demand for digital content this year has created serious compliance...
The Tigerlily Foundation President and Founder is more hopeful than ever that...
The healthcare ecosystem has demonstrated its ability to share data to uncover...
Health inequities, often a legacy of racism, lie heavy on the healthcare sector...
Although the list of cell and gene therapies is growing, prices remain high....
Attempts to make trials more diverse aren’t working. To overcome far-reaching...